Control group:Western antiviral

2 trials

Sponsors

Shenzhen national medicine inheritance medical research institute co. LTD

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Cancelled by the investigator A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19)

Active, not recruitingITMCTR2000003048

Shenzhen national medicine inheritance medical research institute co. LTDNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-24Updated: 2023-02-20

A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000030118

Shenzhen national medicine inheritance medical research institute co. LTDNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-24Updated: 2020-02-25